Home › Funds › venBio Partners LLC › ATOS

venBio Partners LLC position in ATOS

ATOSSA THERAPEUTICS INC · Health Care

venBio Partners LLC reported holding 4,181,366 shares of ATOS (ATOSSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$71.7M, representing 14.45% of its reported portfolio and ranking #3 among its reported holdings. venBio Partners LLC first reported this position in Q3 2026.

Latest position (Q3 2026)4.18M sh
Reported value held$71.67M
Portfolio Weight14.45%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How venBio Partners LLC's ATOS position evolved

venBio Partners LLC first disclosed a stake in ATOS in Q3 2026 at 4,181,366 shares (US$71.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 4.18M $71.67M New

About ATOS and 13F data

ATOS (ATOSSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in ATOS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$120.8M), Deep Track Capital, LP (US$55.0M), EcoR1 Capital, LLC (US$34.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has venBio Partners LLC held ATOS?

venBio Partners LLC has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is venBio Partners LLC's current position in ATOS?

As of Q3 2026, venBio Partners LLC holds 4.18M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $71.67M, representing 14.45% of its reported portfolio and ranking #3.

Has venBio Partners LLC been buying or selling ATOS?

In the latest 13F filing (Q3 2026), venBio Partners LLC newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Frazier Life Sciences Management, L.P., Deep Track Capital, LP, EcoR1 Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.